Product NDC: | 0378-0052 |
Proprietary Name: | Pindolol |
Non Proprietary Name: | pindolol |
Active Ingredient(s): | 5 mg/1 & nbsp; pindolol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-0052 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074019 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100722 |
Package NDC: | 0378-0052-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0052-01) |
NDC Code | 0378-0052-01 |
Proprietary Name | Pindolol |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0052-01) |
Product NDC | 0378-0052 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pindolol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100722 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | PINDOLOL |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |